OneMedNet (NASDAQ:ONMD) Insider Acquires $119,611.50 in Stock

OneMedNet Corporation (NASDAQ:ONMD) insider Jeffrey Yu acquired 173,350 shares of the business’s stock in a transaction that occurred on Tuesday, August 26th. The stock was bought at an average cost of $0.69 per share, for a total transaction of $119,611.50. Following the completion of the transaction, the insider directly owned 6,955,560 shares in the company, valued at $4,799,336.40. This represents a 2.56% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jeffrey Yu also recently made the following trade(s):

• On Thursday, September 25th, Jeffrey Yu bought 1,250 shares of OneMedNet stock. The shares were purchased at an average price of $1.03 per share, with a total value of $1,287.50.
• On Wednesday, September 24th, Jeffrey Yu purchased 17,200 shares of OneMedNet stock. The stock was purchased at an average price of $1.02 per share, for a total transaction of $17,544.00.
• On Tuesday, September 23rd, Jeffrey Yu acquired 5,700 shares of OneMedNet stock. The shares were purchased at an average cost of $0.93 per share, with a total value of $5,301.00.
• On Monday, September 22nd, Jeffrey Yu bought 400 shares of OneMedNet stock. The stock was purchased at an average cost of $0.95 per share, for a total transaction of $380.00.
• On Friday, September 19th, Jeffrey Yu bought 1,250 shares of OneMedNet stock. The stock was purchased at an average price of $0.89 per share, for a total transaction of $1,112.50.
• On Thursday, September 18th, Jeffrey Yu purchased 700 shares of OneMedNet stock. The shares were acquired at an average cost of $0.91 per share, with a total value of $637.00.
• On Friday, September 5th, Jeffrey Yu purchased 2,100 shares of OneMedNet stock. The shares were acquired at an average cost of $0.86 per share, with a total value of $1,806.00.
• On Thursday, September 4th, Jeffrey Yu acquired 11,810 shares of OneMedNet stock. The stock was acquired at an average cost of $0.87 per share, for a total transaction of $10,274.70.
• On Wednesday, September 3rd, Jeffrey Yu bought 11,670 shares of OneMedNet stock. The shares were acquired at an average price of $0.81 per share, with a total value of $9,452.70.
• On Tuesday, September 2nd, Jeffrey Yu bought 24,319 shares of OneMedNet stock. The stock was acquired at an average cost of $0.85 per share, with a total value of $20,671.15.

OneMedNet Price Performance

ONMD stock traded down $0.04 during midday trading on Wednesday, hitting $1.42. The company’s stock had a trading volume of 298,140 shares, compared to its average volume of 762,577. The company’s fifty day moving average price is $1.77 and its 200 day moving average price is $0.99. OneMedNet Corporation has a twelve month low of $0.30 and a twelve month high of $4.22. The stock has a market capitalization of $72.43 million, a P/E ratio of -28.40 and a beta of 1.09.

OneMedNet (NASDAQ:ONMD) last posted its quarterly earnings data on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.18 million for the quarter.

Hedge Funds Weigh In On OneMedNet

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Exencial Wealth Advisors LLC lifted its holdings in shares of OneMedNet by 3.1% during the 2nd quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company’s stock worth $851,000 after acquiring an additional 45,448 shares during the period. Ashton Thomas Private Wealth LLC bought a new position in OneMedNet in the third quarter valued at approximately $25,000. Finally, Correct Capital Wealth Management acquired a new position in OneMedNet during the third quarter valued at approximately $4,910,000. 0.95% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ONMD has been the subject of several recent analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of OneMedNet in a report on Tuesday, October 14th. Wall Street Zen upgraded OneMedNet to a “hold” rating in a research note on Friday, September 26th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.